Vir Biotechnology, Inc. — Director's Dealing 2020

Aug 3, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-07-30

Reporting Person: Rice Steven J. (Chief Administrative Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$12.76	2029-12-10	Common Stock (444444)		Direct

Footnotes

F1: 1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.